A Calgary-based biotechnology company, CardiAI, holds one of the two keys, having developed the world’s most advanced PCR diagnostic test
Philos reader is the world’s first multiport reader capable to read multiple test strip simultaneously to provide users with comprehensive data about their health.
Philos reader is designed for patients to monitor and manage their chronic conditions, including diabetics and cardiovascular ailments.
Philos is a handheld reader that reads the biomarker information from the CardiAI’s electrochemical test strip. Philos has a touch screen interface that allows users to set up their user profile before running a test at the comfort of their homes. The electronics within the device is designed to accept CardiAI Inc’s proprietary strips. On reading the data, the device securely transmits the results to a companion mobile application via Bluetooth, allowing the user to share their health data with their trusted health care professionals.